These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22110586)

  • 1. Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
    Achonu C; Rosella L; Gubbay JB; Deeks S; Rebbapragada A; Mazzulli T; Willison D; Foisy J; McGeer A; Johnson I; LaFreniere M; Johnson C; Willmore J; Yue C; Crowcroft NS
    PLoS One; 2011; 6(11):e26427. PubMed ID: 22110586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.
    Cox CM; Goodin K; Fisher E; Dawood FS; Hamilton JJ; Leparc GF; Gray M; Nelson L; Borse RH; Singleton JA; Reed C; Balish AL; Katz JM; Hopkins RS; Fry AM
    PLoS One; 2011; 6(12):e29301. PubMed ID: 22206008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.
    Kwok KO; Riley S; Perera RAPM; Wei VWI; Wu P; Wei L; Chu DKW; Barr IG; Malik Peiris JS; Cowling BJ
    BMC Infect Dis; 2017 May; 17(1):337. PubMed ID: 28494805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan.
    Chen CJ; Lee PI; Chang SC; Huang YC; Chiu CH; Hsieh YC; Chang SC; Chang FY; Lee JJ; Su SC; Shen GH; Chuang YC; Chen YS; Liu JW; Lin TY
    PLoS One; 2011; 6(9):e24440. PubMed ID: 21909433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.
    Gilbert GL; Cretikos MA; Hueston L; Doukas G; O'Toole B; Dwyer DE
    PLoS One; 2010 Sep; 5(9):e12562. PubMed ID: 20830210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.
    Subelj V; Prosenc K; Sočan M
    Wien Klin Wochenschr; 2012 Mar; 124(5-6):177-80. PubMed ID: 22327938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.
    Zimmer SM; Crevar CJ; Carter DM; Stark JH; Giles BM; Zimmerman RK; Ostroff SM; Lee BY; Burke DS; Ross TM
    PLoS One; 2010 Jul; 5(7):e11601. PubMed ID: 20644650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys.
    Yang F; He J; Zhong H; Ke C; Zhang X; Hong T; Ni H; Lin J
    PLoS One; 2012; 7(6):e38768. PubMed ID: 22719938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
    von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
    PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.
    Dellagi K; Rollot O; Temmam S; Salez N; Guernier V; Pascalis H; Gérardin P; Fianu A; Lapidus N; Naty N; Tortosa P; Boussaïd K; Jaffar-Banjee MC; Filleul L; Flahault A; Carrat F; Favier F; de Lamballerie X
    PLoS One; 2011; 6(9):e25738. PubMed ID: 21980532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A humoral immunity survey following the 2012 influenza season after the pH1N1 pandemic in Guangzhou, China.
    Huang P; Liang LJ; Huang ZZ; Zhang X; Yu SY; Su WZ; Ou CQ; Fang L; Cao DL; Zhang YH; Ke CW
    Viral Immunol; 2014 Apr; 27(3):124-8. PubMed ID: 24702517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.
    McVernon J; Laurie K; Nolan T; Owen R; Irving D; Capper H; Hyland C; Faddy H; Carolan L; Barr I; Kelso A
    Euro Surveill; 2010 Oct; 15(40):. PubMed ID: 20946757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.
    Dowse GK; Smith DW; Kelly H; Barr I; Laurie KL; Jones AR; Keil AD; Effler P
    Med J Aust; 2011 Jan; 194(2):68-72. PubMed ID: 21241219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.